The cancer patient 1-derived CD4+ T cell lines that were harvested from the induction culture responded to the CDCA155-78 and LY6K172-191 peptides in an HLA-DQ or HLA-DR-restricted manner (Fig 7A). This evidence concerns the gene CD4 and cancer.